Evaluation of Xpert MTB/RIF Ultra in Stools and Urine to Improve Tuberculosis Diagnosis in Children

CompletedOBSERVATIONAL
Enrollment

563

Participants

Timeline

Start Date

June 26, 2019

Primary Completion Date

June 1, 2023

Study Completion Date

December 15, 2023

Conditions
TuberculosisPediatric Infectious Disease
Interventions
DIAGNOSTIC_TEST

Xpert MTB/RIF Ultra in stools and urine

All children with presumptive TB had at least 1 sample collected of respiratory or extrapulmonary specimen (considered as gold standard) and 1 sample of stools and 1 sample of urine. All of them were analyzed with Xpert MTB/RIF Ultra.

Trial Locations (2)

Unknown

Simao Mendes hospital, Bissau

Malakal hospital, Malakal

All Listed Sponsors
collaborator

Ministry of Health, Guinea-Bissau

UNKNOWN

collaborator

Ministry of Health, South Sudan

UNKNOWN

collaborator

Institute of Tropical Medicine, University of Tuebingen

OTHER

lead

Medecins Sans Frontieres, Spain

OTHER

NCT06239337 - Evaluation of Xpert MTB/RIF Ultra in Stools and Urine to Improve Tuberculosis Diagnosis in Children | Biotech Hunter | Biotech Hunter